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Abstract
Our previous studies indicated that JWA plays an important role in DNA damage repair, cell migration, and regulation of
MAPKs. In this study, we investigated the role of JWA in chemical carcinogenesis using conditional JWA knockout (JWA
D2/D2)
mice and two-stage model of skin carcinogenesis. Our results indicated that JWA
D2/D2 mice were resistant to the
development of skin papillomas initiated by 7, 12-dimethylbenz(a)anthracene (DMBA) followed by promotion with 12-O-
tetradecanoylphorbol-13-acetate (TPA). In JWA
D2/D2 mice, the induction of papilloma was delayed, and the tumor number
and size were reduced. In primary keratinocytes from JWA
D2/D2 mice, DMBA exposure induced more intensive DNA damage,
while TPA-promoted cell proliferation was reduced. The further mechanistic studies showed that JWA deficiency blocked
TPA-induced activation of MAPKs and its downstream transcription factor Elk1 both in vitro and in vivo. JWA
D2/D2 mice are
resistance to tumorigenesis induced by DMBA/TPA probably through inhibition of transcription factor Elk1 via MAPKs. These
results highlight the importance of JWA in skin homeostasis and in the process of skin tumor development.
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Introduction
Viable cells suffer spontaneous DNA damage or genotoxic
agent-induced DNA damages. Therefore, a network of DNA
surveillance systems has developed in the cells that monitor and
coordinate cell cycle progression with repair of damaged DNA to
maintain genome integrity. Unrepaired DNA lesions may result in
genetic instability, higher frequency of chromosomal aberrations
[1,2] and eventually leading to subsequent tumorigenesis [3,4].
MAPK (Mitogen-activated protein kinase) pathways are in-
volved in the signal transduction of a wide variety of extracellular
stimuli [5,6,7]. There are three such classical pathways that
activate different MAPK classes, known as ERK (extracellular
signal regulated kinase), JNK (Jun N-terminal kinase) and p38,
each pathway evokes distinct biological responses. The MEK/
ERK pathway is activated by mitogenic stimuli and plays an
important role in cell proliferation and differentiation. Activated
ERK phosphorylates and activates its targets such as the
transcription factor Elk1 (Ets-like transcription factor-1), member
of ETS oncogene family. Activated Elk1 organizes ternary
complex factor with serum response factor and binds to the serum
response element of the promoter of the target genes (e.g. c-fos)
and enhances their transcription [8,9,10].
The JWA gene, also known as ARL6ip5 (ADP-ribosylation-like
factor 6 interacting protein 5), was initially cloned from human
tracheal bronchial epithelial cells after treatment with all-trans
retinoic acid [11]. Several JWA homologues (e.g. GTRAP3-18,
addicsin and JM4) were since identified [12,13]. Subsequent
studies indicated that JWA is involved in the cellular responses
to heat shock and chemical-mediated oxidative stresses [14].
JWA plays a key role in protecting cells from DNA damage
induced by oxidative stress [15,16]. On the other hand, there is
an increasing amount of data to indicate that JWA is a
structurally novel microtubule-associated protein, which regu-
lates cancer cell migration via MAPK cascades [17]. Our recent
data have shown that JWA plays an important role in melanoma
metastasis via integrin signaling pathway [18]. However, the
potential role of JWA in chemically induced skin carcinogenesis
has not been elucidated. The purpose of this study was to
characterize the role and the related molecular mechanisms of
JWA in DMBA-TPA induced two-stage skin papilloma devel-
opment in conditional JWA knockout mice. Our results
demonstrate that JWA deletion enhanced cellular DNA damage
induced by DMBA at first stage, nevertheless attenuated tumor
incidence induced by TPA at second stage and probably via
inactivation of MAPK pathway.
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Generation and genotype identification of JWA mice and
cells
The conditional JWA
D2/D2 mice were created by contract
service at the Model Animal Research Center of Nanjing
University, Nanjing, China. Bacterial artificial chromosome-
retrieval methods were used for constructing the targeting vector.
In brief, an 11 kb genomic DNA fragment containing 59 element
to exon2 of the JWA was retrieved from a 129/sv BAC clone
bMO 366n04 by a retrieval vector containing 2 homologous arms.
Exon2, which encodes the majority of conserved PRA-1
(prenylated rab acceptor) domain, was flanked by 2 loxP sites
and an frt-Neo-frt cassette as a positive selection marker. In theory,
this deletion will cause an out-of-frame reading shift and thereby
generate a premature stop codon and a loss-of-function allele
(Fig. 1). Embryonic stem W4 cells were electroporated with the
linearized targeting vector, selected, then expanded for Southern
blot analysis. Chimeric mice were generated by injecting ES cells
into C57BL/6 blastocysts followed by transferring to pseudopreg-
nant mice. These chimeric mice (JWA
loxP/+) were viable and finally
interbred to generate JWA
loxP/loxP mice, which are healthy, fertile
and have reached maturity. To generate JWA
D2/+ mice,
JWA
loxP/loxP mice were crossed with mice transgenic for EIIa-Cre
(adenovirus early transcription region IIa promoter-Cre), which
express Cre in germ cells. JWA null mutant mice (JWA
D2/D2) were
produced by intercrossing the JWA
D2/+ mice. Subsequent
breeding yielded genotypes for experiments. All experiments were
conducted in accordance with Animal Care and Use Committee
of Model Animal Research Centre.
For mice and cells genotyping, genomic DNA from the tip of
tail of 4-week-old pups or cells was extracted by means of standard
protocols. The following primers were used for simultaneous
detection of wild-type and null JWA alleles: 59-CCACTGT-
TTCCTCTGTTG (P1, forward primer for wild-type and null
JWA); 59-GTGAAAACCACTGAGAACC (P2, reverse primer for
wild-type JWA); 59-CAGATGTTCCTCGTGTATC (P3, reverse
primer for null JWA). 59-ATCAACGTTTTCTTTTCGG (for-
ward primer for cre) and 59-ATTTGCCTGCATTACCGGTC
(reverse primer for cre).
Figure 1. The construction and genotype verification of JWA knockout mice. (A) Schematic representation of JWA gene-targeting strategy.
Exon2 of JWA was floxed with Loxp site (JWA
L), after Cre mediated recombination, the exon2 was deleted (JWA
D2). (B, C) Genotyping of Loxp mice by
PCR. Forward (P1) and reverse (P2) primers used in PCR analysis were shown in (B), the products of PCR acquired were about 437 bp after Loxp
inserted. (D, E) Genotyping of EIIa Cre mice. (F–I) Genotyping of JWA knockout mice at DNA level. The primers used were shown in (F) and (G). (H)
Genotyping of JWA
D2/D2 and JWA
D2/+ mice by PCR with paired primers. (I) Sequencing result of 341 bp product after exon2 deleted. (J–L) Genotyping
of JWA knockout mice at mRNA level. Primers used in RT-PCR analysis were shown in (J). PCR results were shown in (K). The sequencing result of
187 bp product was shown in (L), which is comparable with the Entrze JWA sequence (NM_022992.2). NC, negative control; M, marker. For all the
experiments, markers were 600 bp, 500 bp, 400 bp, 300 bp, 200 bp, 100 bp in order. (M) The skin protein from JWA
+/+, JWA
D2/+ and JWA
D2/D2 mice
were analyzed by Western-blot. b-actin was used as the loading control.
doi:10.1371/journal.pone.0034154.g001
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RNA from mice or cells was transcribed and subjected to RT-
PCR analysis by standard protocol. The following primers were
used for detection of JWA
+/+ and JWA
D2/D2 mice: 59-AACC-
GTGTAGTGAGCAATCTTG (forward primer) and 59-GGA-
TAATGCCCATCGGAGT (reverse primer). The PCR products
from genomic DNA and cDNA were subject to further sequencing
analysis for final verification.
Skin papilloma induction by DMBA/TPA
All the mice used for experiments were maintained in the
C57BL/6 background with at least six backcrosses from the
original 129Sv/C57BL/6 founder mice. Both wild type and
JWA
D2/D2 mice were used in this DMBA/TPA two-stage
papilloma induction assay. All the genotypes of mice and cells
were verified at genomic DNA and cDNA level, respectively. A
total of 48 mice (8–9 weeks old) were divided into 2 groups, each
with either the JWA
+/+ (n=24) or JWA
D2/D2 (n=24) genotype
and identical number of male (n=10) and female (n=14) mice.
To induce skin papillomas, mice were shaved on their dorsal
skin, and 2 days later treated topically with 25 mg of DMBA
(Sigma, St. Louis, MO) in 100 ml acetone once. One week later,
each animal received subsequent topical treatments of 2.5 mgo f
TPA (Sigma, St. Louis, MO) in 100 ml acetone twice a week for 19
weeks. Treated mice were examined twice a week for detecting the
presence of skin papillomas, which were not scored as positive
until they reached at least 1 mm in diameter. At the end of the
two-stage model, all mice were sacrificed, and skin papillomas
were counted and isolated for further histological analysis. All
experiments were conducted in accordance with Animal Care
Committee of Nanjing Medical University.
Histological and immunohistochemical analyses
Dorsal skin and papilloma samples were isolated and fixed in
4% paraformaldehyde at 4uC overnight, embedded in paraffin,
and sectioned as 4 mm slides. The sectioned tissues on slides were
stained with hematoxylin and eosin. Immunohistochemical
staining was further carried out using indicated first antibodies
and the Immuno Cruz Staining Systems (Zhongshan Golden
Bridge Biotechnology, Beijing, China). The endogenous peroxi-
dase activity in the specimens was blocked by treatment of 0.3%
H2O2 and the samples were then rinsed with PBS. The specimens
were probed consecutively with primary antibody against PCNA
(1:100, Epitomics, California, USA), Ki67 (1:200, Abcam, Cam-
bridge, UK) for 2 h, biotin-conjugated goat anti-rabbit IgG for
30 min, horseradish peroxidase-streptavidin complex, and then
developed with diaminobenzidine.
Preparation of mouse embryonic fibroblast (MEF) and
keratinocytes
On day 13.5 of gestation, embryos from JWA
+/D26JWA
+/D2
crossed females were harvested. Embryo head and all visible organs
(heart, spleen, etc.) were removed. Remaining embryo was put in
50 ml tube and minced with scissors. 5 ml 0.25% trypsin was added
and incubated in 37uC water bath for 20 min. Trypsin was
inactivated using 5 ml of Dulbecco’s Modified Eagle Medium
(DMEM) containing 10% fetal bovine serum. The harvested cells
werecentrifugedtopelletat15006g for 5 min and then resuspended
with15 mloffreshmedium.Cellsuspensionwasallowedtostandfor
5–10 min to let the debris settle to the bottom. Top 10 ml of
medium containing cells was removed and plated in a 100-mm dish.
For isolating keratinocytes, full-layer skin removed from newborn
(1–2 days old) mice was treated with 0.25% trypsin (Invitrogen)
overnight at 4uC. The epidermis was then peeled off from the
dermis and minced into pieces smaller than 1 mm, and placed into
a sterile flask, dispersed by stirring into single cells for 30–60 min,
suspended in keratinocyte-SFM with supplements (Invitrogen).
Cells were first incubated in dishes coated with type I collagen at
34uCi n5 %C O 2 for 12 h to allow cells to attach. Unattached cells
were removed by washing with PBS. Attached cells were further
cultured in fresh medium, which was refreshed every 2 days.
Neutral comet assay
The keratinocytes were cultured in standard medium for 4 days,
and then treated with or without 0.15 mg/ml DMBA for another
24 h. The comet assay was carried out according to the
manufacturer’s instructions. Briefly, cells at a concentration of
5610
5/ml in PBS were mixed gently with pre-melted low-
temperature-melting agarose at a volume ratio of 1 to 9 (v/v) and
spread on glass slides which were coated with normal-temperature
agarose. The slides were then submerged in pre-cooled neutral
lysis buffer at 4uC for 90 min. After rinsing, the slides were
electrophoresed at constant 25 V, 300 mA for 20 min, then
equilibrated in Tris-borate EDTA solution, and stained with
ethidium bromide. Fluorescent images for at least 50 nuclei were
captured using an Olympus microscope and analyzed by CASP-
1.2.2 software for tail moment.
Immunofluorescence
Cells grown on coverslips for 24 h were treated with or without
0.15 mg/ml DMBA for 24 h. After washing with PBS three times,
cells were fixed with methanol for 10 min followed with PBS wash
twice, and then incubated in PBS containing 5% BSA for 1 h.
After washing with PBS twice, the cells were incubated with anti-
phosphorate c-H2AX primary antibody (1:300, Upstate, NY) in
PBS containing 5% BSA at 4uC overnight. Afterwards, coverslips
were washed twice for 5 min in PBS and incubated with Texas
Red-conjugated anti-mouse antibody (1:300 in PBS containing 5%
BSA) for 1 h. Finally, coverslips were counterstained with DAPI
(10 ng/ml) for 10 min. The images were captured using a
fluorescent microscope.
Quantitative real-time PCR
Total RNA was extracted from cells or tissues with TRIzol
(Invitrogen). Total RNA (2 mg) was reverse transcribed with oligo
(d18T) primer using the M-MLV reverse transcriptase for RT-
PCR. The cDNA was used as template for quantitative real-time
PCR analysis, preformed using SYBR Premix Ex Taq Mix
(TaKaRa) with ABI Prism 7900 sequence detection system.
Reactions were in triplicate for each sample and data were
normalized by GAPDH levels. The following primer pairs were
used for the PCR reactions: Elk1, forward primer(F): 59-T-
TTGTGTCCTACCCAGAGGTT-39 and reverse primer (R): 59-
CTGCACCCTTTGGTGTTCC-39; c-fos, F: 59-CCCATCCT-
TACGGACTCCC- 39 and R: 59-GAGATAGCTGCTCTACT-
TTGCC-39; c-myc, F: 59-TCTCCATCCTATGTTGCGGTC-39
and R: 59- TCCAAGTAACTCGGTCATCATCT-39; PCNA, F:
59-TGCTCTGAGGTACCTGAACT-39 and R: 59- TGCTTC-
CTCATCTTCAATCT-39; GAPDH, F: 59-ACAGCCGCATC-
TTCTTGTGC-39 and R: 59-CACTTTGCCACTGCAAATGG-
39. We used the following PCR procedure: 94uC for 10 min, then
40 cycles of 95uC for 15 s, 60uC for 1 min, 72uC for 45 s.
Western blot analysis
Papillomas and dorsal skin of the mice were isolated and
homogenized with a grinder for 10 min in RIPA lysis buffer as
JWA Is Required for Induction of Skin Papillomas
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cell extract protocols from cell pellets in protein lysis buffer
containing protease and phosphatase inhibitors. Western blot
analysis was performed by standard procedures [18]. Membranes
were incubated with antibodies detecting phosphorylated B-Raf
(Ser 445), MEK (Ser 217/221), ERK1/2 (Thr202/Tyr204), JNK
(Thr183/Tyr185), p38 (Thr180/Tyr182), total B-Raf, MEK,
ERK1/2 , JNK, p38 and a-tubulin (1:1000, all from Cell
Signaling Technology, Inc. Danvers, MA); JWA (1:1000, Imgenex,
San Diego, CA, USA), Elk1, c-fos, c-myc (1:1000, Bioworld,
Atlanta, Georgia); PCNA (1:2000, Epitomics, California, USA), b-
actin (1/1000, Boster Technology, Wuhan, China)
Statistical analysis
Data were analyzed by Prism software 5.0 (GraphPad Software
Inc., La Jolla, CA). The Kaplan-Meier method was used for
comparison of the tumor development induced by DMBA/TPA.
The Student’s t-test was performed to determine statistical
significance for neutral comet assay and relative expression levels.
Wilcoxon rank-sum test was used to compare the difference in
tumor numbers. In all the above analyses, a P value of ,0.05 was
considered statistically significant.
Results
Targeted disruption of the mouse JWA gene
To investigate the role of JWA in the development of
mammalian skin tumors, we constructed the conditional JWA
knockout mice. Exon2 of JWA was floxed with Loxp site (JWA
L),
after Cre mediated recombination, the exon2 was deleted (JWA
D2)
(Fig. 1A). The conditional JWA knockout mice (JWA
D2/D2) were
produced by intercrossing the JWA
D2/+ mice. Genotyping of Loxp
was shown in Fig. 1B (PCR primers location) and Fig. 1C (LoxP
marker was shown in lanes contain 437 bp) and genotyping of EIIa
Cre was indicated in Fig. 1D–E. Genotyping of JWA knockout
mice were identified at genome DNA level (Fig. 1F–G for primers
location; Fig. 1H for PCR products: non product for P1–P2
amplification in JWA
D2/D2, 341 bp for JWA
D2/+and JWA
+/+,
423 bp for JWA
D2/+and JWA
D2/D2 in P1–P3 products; and
sequncing confirmed in Fig. 1I); mRNA level (Fig. 1J–L) and
Figure 2. Mouse skin papillomas induced by DMBA/TPA. (A) Papillomas induced by DMBA/TPA treatment in JWA
+/+ mouse skin (left). Arrow
indicates the papilloma. (B) Comparison of the percentage of papilloma-free mice between JWA
+/+ and JWA
D2/D2 groups after DMBA/TPA treatment.
***P,0.001. (C) Comparison of average numbers of papillomas per mouse between JWA
+/+ and JWA
D2/D2 groups. ***P,0.001. (D) Comparison of
papilloma size distribution between JWA
+/+ and JWA
D2/D2 groups. The diameter of papillomas was used to represent the tumor size. *P,0.05,
**P,0.01. (E) H&E staining for typical papillomas from both JWA
+/+ and JWA
D2/D2 mice.
doi:10.1371/journal.pone.0034154.g002
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D2/D2 mice developed
premature ageing like phenotypes such as decreased body weight,
kyphosis, osteoporosis, and immune organ atrophy, we have not
found any spontaneous tumors during their lifespan (described
elsewhere).
JWA deficiency attenuates the development of mouse
skin papillomas
As shown in Fig. 2A, skin papilloma was induced by DMBA/
TPA treatment in both JWA
+/+ and JWA
D2/D2 mouse skin. In the
present study, the first papilloma was observed after 8 weeks of
TPA treatment in JWA
+/+ mouse and appeared 2 weeks later in
JWA
D2/D2 mouse than in JWA
+/+ mouse (Fig. 2B). At the 19
th
week of TPA treatment, the end point of experiment, 11 JWA
+/+
mice and 6 JWA
D2/D2 mice developed skin papillomas. The ratio
of tumor induction in JWA
+/+ mice was significantly higher than
in JWA
D2/D2 mice (P,0.001). There were significantly fewer
number and smaller sizes of papillomas occurred in JWA
D2/D2
mice than in JWA
+/+ mice (P,0.05 and P,0.01, respectively;
Fig. 2 C and D). Skin specimens with H&E staining confirmed that
the papillomas with no significant difference between the mice
(Fig. 2E). These data suggest that JWA deficiency attenuates the
initiation and development of mouse skin papillomas induced by
DMBA/TPA treatment.
JWA deficiency inhibits DMBA/TPA induced cell
proliferation
To understand whether reduced papillomas in JWA knockout
mice was due to inhibition of cell proliferation, expression of
PCNA in mouse papillomas and skin tissues nearby was analyzed.
As we predicted, data showed the expressions of mRNA (P,0.01)
(Fig. 3A), protein (Fig. 3B), and the amount of PCNA-positive
cells in papillomas was significantly higher in JWA
+/+ than in
JWA
D2/D2 mice (P,0.05) (Fig. 3C and D). Similar result was
obtained from the expression of Ki67 in mouse papillomas
(Fig. 3E and F). In addition, the expression levels of PCNA
between mouse skin tissues and the papillomas have shown no
difference (Fig. S1).
Figure 3. The expression of PCNA and Ki67 in mouse papillomas treated with DMBA/TPA. PCNA expression in the papillomas of JWA
+/+
and JWA
D2/D2 mice (n=3) treated with DMBA/TPA was analyzed at mRNA level by real-time PCR (A) and protein level by Western blotting (B).
* P,0.05. (C, E) Typical PCNA and Ki67 immunostaining in papillomas from JWA
+/+ and JWA
D2/D2 mice. Arrows indicate PCNA and Ki67 positive cells.
(D, F) The numbers of PCNA and Ki67 positive epidermal cells were counted from at least 100 cells in five separate fields for each section respectively
(n=3). *P,0.05. Data were presented as means 6 s.d. from three independent experiments.
doi:10.1371/journal.pone.0034154.g003
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of MAPKs
Cellular proliferation can be mediated by the activation of
MAPK signal pathway. We previously reported that JWA as critical
activator of MAPK signal pathway involves in the regulation of cell
migration [17]. ERK activity was essential for the development of
skin papillomas induced by the classic DMBA/TPA skin carcino-
genesis protocol [19,20]. To determine whether JWA deficiency
attenuated papilloma formation was due to inactivation of MAPKs
in mice; both papillomas and skin tissues nearby were extracted for
Western blot analysis. As a result, compared to the JWA
+/+ mice,
less activation of p-MEK and p-ERK in JWA
D2/D2 mice was found
(Fig. 4A and B), although the total expressions of MEK and ERK
wereunaffected. Interestingly, both phosphorylation and expression
of JNK and p38 proteins were also unaffected in papillomas of both
JWA
+/+ and JWA
D2/D2 mice (Fig. S2A).
The primary keratinocytes of the both genotypes mice were
isolated to verify if JWA deletion blocks the role of TPA on the
activation of MAPKs. As shown in Fig. 4C, TPA treatment resulted
in more intensive phosphorylations of MEK and ERK in JWA
+/+
keratinocytes, however, this effect was obviously reduced and did
not last in JWA
D2/D2 keratinocytes. Furthermore, our data also
confirmed in vivo result that TPA had no effect on JNK and p38
proteins in both JWA
+/+ and JWA
D2/D2 keratinocytes (Fig. S2B).
JWA regulates transcription factor Elk1 via MEK/ERK
pathway
It has been reported that transcription factors Elk1, c-fos and c-
myc are all highly related to cell proliferation, and regulated by
MEK/ERK pathway [21,22]. We investigated if the role of JWA
on PCNA was mediated by any of these transcription factors. As a
result, compared to JWA
+/+mice, only expressions of Elk1 at both
mRNA (P,0.05) (Fig. 5A and Fig. S3A) and protein (Fig. 5B and
Fig. S3B) levels were significantly down-regulated in JWA
D2/D2
mouse papillomas and skin tissues.
To investigate if TPA treatment would affect Elk1 expression
via activation of MAPKs, we treated JWA
+/+ and JWA
D2/D2
keratinocytes with TPA and found that Elk1 expression was only
increased in JWA
+/+ keratinocytes (Fig. 5C). There was no
significant difference in protein level of c-fos and c-myc in
keratinocytes of both genotypes after treatment with TPA alone or
with the MEK inhibitor U0126. Similarly, TPA induced Elk1
Figure 4. TPA-stimulated phosphorylations of MAPKs in JWA
+/+ and JWA
D2/D2mouse papillomas, skin tissue and keratinocytes. (A–B)
Epidermal lysates were prepared in tissue protein extraction buffer from JWA
+/+ and JWA
D2/D2 mouse papillomas (A) and skin (B) treated with DMBA/
TPA at the end point of experiment. Total protein (60 mg per well) from paired samples (n=3) was run on SDS-PAGE and probed with antibodies for
phosphorylated or total amounts of B-Raf, MEK and ERK. (C) JWA
+/+ and JWA
D2/D2 keratinocytes were treated with 100 ng/ml TPA at indicated time
points. Phosphorylations or total amounts of B-Raf, MEK and ERK were determined by Western blotting. b-actin was used as the loading control. Each
experiment was performed in triplicate.
doi:10.1371/journal.pone.0034154.g004
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(Fig. 5D–F). Similar results were obtained from MEFs (Fig. S3C–
F). These data provide further evidence that JWA may regulate
Elk1 transcription factor via MEK/ERK pathway.
JWA deficiency enhances DMBA-induced DNA damage
MAPK pathway was shown to be involved in DNA damage
repair process [23,24]. To investigate if MAPK pathway is
involved in DMBA-induced DNA damage repair, phosphoryla-
tions of MEK/ERK were examined and results indicated that
DMBA does not cause significant change on MEK/ERK
phosphorylation (Fig. S4).
Since JWA is a DNA damage repair associated protein, we
further investigated if JWA deficiency enhances DMBA-induced
DNA damage and genome instability. The neutral comet assay
was used to detect DNA double strand breaks (DSBs) of
keratinocytes induced by DMBA treatment. As a result, DMBA
induced more DSBs in JWA
D2/D2 keratinocytes than in JWA
+/+
cells (P,0.01) (Fig. 6A and B). Consistent with the result from
neutral comet assay, JWA
D2/D2 keratinocytes had more c-H2AX
positive foci than in JWA
+/+ cells after DMBA exposure (P,0.05)
(Fig. 6C and D).
Discussion
JWA was initially isolated as an all-trans-retinoic acid responsive
and cytoskeleton-associated gene [11]. Previously, we identified
JWA as a novel mitogen activated protein, which binds to a- and
b-tubulin and is essential for the rearrangement of F-actin
cytoskeleton and activation of MAPK cascades induced by
As2O3 and TPA [17]. Down-regulation of JWA accelerates
melanoma cell migration and adhesion, and promotes cell invasion
through matrigel-coated chamber in vitro [18]. On the other hand,
JWA was regulated by environmental stressors such as heat shock
and oxidative stress [14,25]. JWA also participated in the
protection of cells from oxidative stress-induced DNA damage
[15]. Therefore, JWA is precisely involved in both DNA damage
repair process and regulation of MAPK pathway. In the present
study, we examined whether combined treatment with DMBA
and TPA will affect the development of skin papillomas in
JWA
D2/D2 mice. The data showed that although JWA deficiency
enhanced DMBA-induced DNA damage in vitro, TPA promotion
on the development of skin papillomas was reduced in JWA
D2/D2
mice compared with JWA
+/+ mice. These results verified the
unique role of MEK/ERK in TPA tumor promotion model and
Figure 5. Transcription factor Elk1 was regulated by JWA. (A–B) Elk1, c-fos and c-myc expression in the papillomas from JWA
+/+ and JWA
D2/D2
mice (n=3) were analyzed at mRNA level by real-time PCR (A) and at protein level by Western blotting (B). (C) JWA
+/+ and JWA
D2/D2 keratinocytes
were treated with or without 100 ng/ml TPA for 30 min or with 5 mg/ml U0126 (MEK inhibitor) for 6 h to silent MEK/ERK signaling, and then treated
with 100 ng/ml TPA for 30 min. Related protein expressions were shown. (D–F) The mRNA expression of Elk1 (D), c-fos (E) and c-myc (F) in JWA
+/+ and
JWA
D2/D2 keratinocytes were analyzed by real-time PCR after TPA and/or U0126 treatment. *P,0.05. Data were presented as means 6 s.d. from three
independent experiments.
doi:10.1371/journal.pone.0034154.g005
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important checkpoint.
It has been understood for many years that skin carcinogenesis
is a multistep process of several separable genetic alterations [26].
The results of mouse skin chemical carcinogenesis studies have
provided a conceptual framework for malignant progression. The
oxidation of DMBA by P450 enzymes produces metabolites that
form covalent adducts with DNA and the formation within DNA
of depurinated abasic sites and induces genetic alteration whereby
normal cells are converted to a premalignant state. Several DNA
repair genes are involved in this step, such as Sirt1, Rad1, Rad9,
etc. Rad1 and Rad9 are important for preventing tumor
development, probably through maintaining genomic integrity
[27,28], while Sirt1 does not behave like a classical tumor-
suppressor but partly participates the antitumor activity of
resveratrol [29]. Our present study suggests that JWA, as a
DNA repair protein, actively responds to DMBA-induced cell
stress, which is consistent with the previous studies [15,16]. JWA
deficiency cells acquired more severe injury than JWA wild type
cells, suggesting JWA deletion increased the susceptibility to tumor
induction might be due to reduced DNA repair capacity of cells.
This seems to be contradictory to the results from skin
carcinogenesis animal model showing that JWA deficiency
attenuated tumor formation induced by DMBA/TPA treatment.
However, further evidences indicate that JWA deficiency effec-
tively inhibits TPA promotion step. TPA is considered to promote
DNA damaged cells to enter hyper-proliferative state via activating
transcriptional factors. This step results in clonal expansion of cells
to form benign premalignant lesions called papillomas. This
promotion step is always involved in the activation of B-Raf/
MEK/ERK pathway [19,30], since this pathway is identified to
regulate fundamental processes in normal and malignant cells,
including proliferation and cell survival [31]. In response to tumor
promotion induced by TPA, the inhibition of MEK/ERK is
beneficial because it prevents skin tumor development [20,32,33].
We have previously shown that JWA is an upstream activator of
MEK. Further analysis in JWA knockout keratinocytes and MEFs
revealed that JWA is required for TPA-induced MEK and ERK
phosphorylation. Consistent with this result, there was a
remarkable decrease in the expression of PCNA in JWA
D2/D2
mice. Therefore, our data indicated that in DMBA/TPA two-
stage skin papilloma induction model, MEK-ERK activation is
critical for the second step. Without effective activation of MEK-
ERK, the cells are less prone to papilloma development even they
receive severe DNA damage.
AP-1, which consists of a family of Jun/Fos dimers, is a major
positive regulator of cell proliferation and transformation and can
be activated by TPA in the skin [34,35,36]. In this study, however,
we did not find any positive role of AP-1 during DMBA/TPA
papilloma induction. Elk1, as a member of ETS oncogene family,
is an identified target of MAPK which has been reported to play a
key role in cell proliferation [21,37,38]. We found reduced Elk1
expression in JWA
D2/D2 mouse skin tissues as well as in cultured
JWA
D2/D2 MEFs, suggesting that Elk1 may be involved in TPA
induced cell proliferation.
The other two MAP kinase pathways (JNK and p38) have
observed to counteract malignant transformation under the stress
response [31]. Consistent with those findings, we observed that,
Figure 6. JWA deficiency enhances the DMBA-induced DNA damage. (A) DNA strand breaks in JWA
+/+ and JWA
D2/D2 keratinocytes after
DMBA treatment. Cells were either treated with or without 0.15 mg/ml DMBA for 24 h, and DNA strand breaks were detected by neutral comet assay.
(B) Quantification of comet tail movement in (A) from 50 cells in each sample in three independent experiments. **P,0.01. (C) c-H2AX staining in
JWA
+/+ and JWA
D2/D2 keratinocytes after DMBA treatment. Cells were treated with or without 0.15 mg/ml DMBA for 24 h, and DNA strand breaks were
detected with c-H2AX labeling. (D) Quantification of c-H2AX foci. Foci were counted in at least 50 cells for each sample, and the results were
presented as the mean 6 s.d. * P,0.05.
doi:10.1371/journal.pone.0034154.g006
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phosphorylations of neither p38 nor JNK in both skin tissue and
keratinocytes.
In this study, the reduced skin tumor formation observed in the
JWA
D2/D2 mice might be also partially contributed by the similar
mechanisms of premature ageing like phenotype, however, the
exact molecular evidences need to be further provided. To exclude
the contribution of non cell autonomous effects in skin tumor
phenotypes observed in the full knockout mice, future studies
should include the conditional deletion of this gene from the skin.
In summary, we demonstrate for the first time that JWA
deficiency enhances DNA damage in epidermal cells induced by
DMBA, however, suppresses TPA-induced MEK-ERK activation,
cell proliferation, and formation of skin papillomas. These data has
potential clinical implications for targeting JWA in chemopreven-
tion and therapy of skin tumors.
Supporting Information
Figure S1 The expression of PCNA in mouse skin
treated with DMBA/TPA. PCNA expression in the skin of
JWA
+/+ and JWA
D2/D2 mice (n=3) treated with DMBA/TPA was
analyzed at mRNA level by real-time PCR (A) and protein level by
Western blotting (B). * P,0.05. (C) Typical PCNA immunostain-
ing in skin from JWA
+/+ and JWA
D2/D2 mice. Arrows indicate
PCNA-positive cells. (D) The numbers of PCNA positive
epidermal cells were counted from at least 100 cells in five
separate fields for each section (n=3). *P,0.05. Data were
presented as means 6 s.d. from three independent experiments.
(TIF)
Figure S2 TPA-stimulated phosphorylations of MAPKs
in JWA
+/+ and JWA
D2/D2 mouse skin and keratinocytes.
(A) Skin lysates were prepared in tissue protein extraction buffer
from JWA
+/+ and JWA
D2/D2 mouse skin treated with DMBA/
TPA at the end point of experiment. Total protein (60 mg per well)
from paired samples (n=3) was run on SDS-PAGE and probed
with antibodies for phosphorylated or total amounts of JNK and
p38. (B) JWA
+/+ and JWA
D2/D2 keratinocytes were treated with
100 ng/ml TPA for the time period indicated, and phosphorylated
or total amounts of JNK and p38 were detected by Western
blotting. Each experiment was performed in triplicate.
(TIF)
Figure S3 Transcription factor Elk1 was regulated by
JWA. (A, B) Elk1, c-fos and c-myc expression in the skin of
JWA
+/+ and JWA
D2/D2 mice (n=3) were analyzed at mRNA level
by real-time PCR (A) and at protein level by Western blotting (B).
(C) JWA
+/+ and JWA
D2/D2 MEFs were treated with or without
100 ng/ml TPA for 30 min or with 5 mg/ml U0126 (MEK
inhibitor) for 6 h to silent MEK/ERK signaling, and then treated
with 100 ng/ml TPA for 30 min. Related protein expressions
were shown. (D–F) mRNA expression of Elk1 (D), c-fos (E) and c-
myc (F) in JWA
+/+ and JWA
D2/D2 MEFs were analyzed by real-
time PCR after TPA and/or U0126 treatment. * P,0.05. Data
were presented as means 6 s.d. from three independent
experiments.
(TIF)
Figure S4 The effect of DMBA on phosphorylation of
MEK and ERK. JWA
+/+ and JWA
D2/D2 keratinocytes were
treated with or without 100 ng/ml DMBA for 30 min or with
5 mg/ml U0126 for 6 h, then by 100 ng/ml DMBA for further
30 min. Phosphorylated or total MEK, ERK expression was
determined by Western blotting. b-actin was used for loading
control.
(TIF)
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